STOXX 600Health Care· United Kingdom

SN

Challenger

Smith & Nephew

$1,263.00

+1.69%

Open $1,249.50·Prev $1,242.00

as of 14 Apr

CHALLENGER

Power Core

Smith & Nephew's moat, to the extent one exists, is a diversified medtech portfolio spanning orthopedics, sports medicine, and wound care that creates cross-selling leverage without single-segment dominance.

Published17 Apr 2026

UniverseSTOXX 600

SectorHealth Care

↑

Direction of Movement

upward

Financials